Geneva Capital Management LLC Edwards Lifesciences Corp Transaction History

Geneva Capital Management LLC

  • $5.68 Billion
  • Q4 2024

A detailed history of Geneva Capital Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Geneva Capital Management LLC holds 15,230 shares of EW stock, worth $1.08 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
15,230
Previous 16,322 6.69%
Holding current value
$1.08 Million
Previous $1.08 Million 4.64%
% of portfolio
0.02%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
SELL
$64.54 - $75.92 $70,477 - $82,904
-1,092 Reduced 6.69%
15,230 $1.13 Million
Q3 2024

Nov 05, 2024
SELL
$59.7 - $93.78 $84,475 - $132,698
-1,415 Reduced 7.98%
16,322 $1.08 Million
Q2 2024

Aug 14, 2024
BUY
$84.3 - $94.31 $1.5 Million - $1.67 Million
17,737 New
17,737 $1.64 Million
Q1 2024

May 03, 2024
SELL
$72.54 - $95.56 $80,084 - $105,498
-1,104 Reduced 4.75%
22,158 $2.12 Million
Q4 2023

Feb 06, 2024
SELL
$61.71 - $77.76 $71,892 - $90,590
-1,165 Reduced 4.77%
23,262 $1.77 Million
Q3 2023

Nov 13, 2023
SELL
$69.28 - $93.38 $649,707 - $875,717
-9,378 Reduced 27.74%
24,427 $1.69 Million
Q2 2023

Aug 01, 2023
SELL
$81.41 - $94.33 $115,846 - $134,231
-1,423 Reduced 4.04%
33,805 $3.19 Million
Q1 2023

May 12, 2023
SELL
$74.26 - $84.51 $194,709 - $221,585
-2,622 Reduced 6.93%
35,228 $2.91 Million
Q4 2022

Feb 07, 2023
BUY
$68.3 - $87.44 $88,038 - $112,710
1,289 Added 3.53%
37,850 $2.82 Million
Q3 2022

Nov 02, 2022
BUY
$82.37 - $107.29 $3.01 Million - $3.92 Million
36,561 New
36,561 $3.02 Million
Q2 2022

Aug 02, 2022
SELL
$86.5 - $128.27 $34,859 - $51,692
-403 Reduced 1.09%
36,573 $3.48 Million
Q1 2022

May 02, 2022
BUY
$101.96 - $128.34 $42,823 - $53,902
420 Added 1.15%
36,976 $4.35 Million
Q4 2021

Feb 02, 2022
SELL
$106.37 - $130.68 $94,988 - $116,697
-893 Reduced 2.38%
36,556 $4.74 Million
Q3 2021

Nov 08, 2021
SELL
$102.91 - $122.75 $111,451 - $132,938
-1,083 Reduced 2.81%
37,449 $4.24 Million
Q2 2021

Aug 11, 2021
SELL
$83.84 - $104.76 $14,001 - $17,494
-167 Reduced 0.43%
38,532 $3.99 Million
Q1 2021

May 03, 2021
BUY
$78.68 - $90.67 $356,341 - $410,644
4,529 Added 13.25%
38,699 $3.24 Million
Q4 2020

Feb 02, 2021
BUY
$71.69 - $91.23 $2,580 - $3,284
36 Added 0.11%
34,170 $3.12 Million
Q3 2020

Nov 12, 2020
BUY
$67.19 - $87.44 $20,761 - $27,018
309 Added 0.91%
34,134 $2.73 Million
Q2 2020

Aug 13, 2020
BUY
$57.54 - $76.95 $1.3 Million - $1.74 Million
22,650 Added 202.68%
33,825 $2.34 Million
Q1 2020

May 15, 2020
BUY
$52.41 - $81.0 $585,681 - $905,175
11,175 New
11,175 $2.11 Million

Others Institutions Holding EW

# of Institutions
1,364
Shares Held
475M
Call Options Held
9.74M
Put Options Held
3.85M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $43.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Geneva Capital Management LLC Portfolio

Follow Geneva Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneva Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geneva Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email